Recent advances in nanoformulation-based delivery for cancer immunotherapy

Seyedeh Saimeh Bokhari,Tayyab Ali,Muhammad Naeem,Fatma Hussain,Abdul Nasir
DOI: https://doi.org/10.1080/17435889.2024.2343273
2024-05-10
Nanomedicine
Abstract:Cancer is one of the leading causes of mortality worldwide, and its treatment faces several challenges. Phytoconstituents derived from recently discovered medicinal plants through nanotechnology potentially target cancer cells via PI3K/Akt/mTOR pathways and exert their effects selectively through the generation of reactive oxygen species through β-catenin inhibition, DNA damage, and increasing caspase 3/9 and p53 expression. These nanocarriers act specifically against different cancer cell lines such as HT-29, MOLT-4 human leukemia cancer and MCF-7 cell lines SKOV-3, Caov-3, SW-626, HepG2, A-549, HeLa, and MCF-7. This review comprehensively elaborates on the cellular and molecular mechanisms, and therapeutic prospects of various plant-mediated nanoformulations to attain a revolutionary shift in cancer immunotherapy.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?